Clinical Trial Update: Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating venetoclax in combination with R-ICE chemotherapy for relapsed/refractory diffuse large B-cell lymphoma is active not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• R-ICE
• Venetoclax (venetoclax)

Snippet

Sponsor: Molly Gallogly | Conditions: Diffuse Large B-cell-lymphoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING